• Explore /
  • Poster
  • / Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.

Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.

Abstract Poster

Authors

Georg Pfeiler

Georg Pfeiler

Department of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria

Georg Pfeiler , Robert Königsberg , Lidija Filipcic , Richard Greil , Herbert Stoger , Christian F. Singer , Michael Knauer , Guenther G. Steger , Michael Seifert , Peter Christian Dubsky , Florian Fitzal , Marija Balic , Vesna Bjelic-Radisic , Brigitte Mlineritsch , Christian Marth , Michael Gnant

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 577)

DOI

10.1200/jco.2014.32.15_suppl.577

Abstract #

577

Poster Bd #

41

Abstract Disclosures

Similar Posters

First Author: Georg Pfeiler

First Author: G. Pfeiler

First Author: M. Gnant

First Author: Megan Elizabeth Tesch